Literature DB >> 28259037

Altered soluble epoxide hydrolase-derived oxylipins in patients with seasonal major depression: An exploratory study.

Marie Hennebelle1, Yurika Otoki2, Jun Yang3, Bruce D Hammock4, Anthony J Levitt5, Ameer Y Taha6, Walter Swardfager7.   

Abstract

Many cytochrome p450-derived lipids promote resolution of inflammation, in contrast to their soluble epoxide hydrolase(sEH)-derived oxylipin breakdown products. Here we compare plasma oxylipins and precursor fatty acids between seasons in participants with major depressive disorder with seasonal pattern (MDD-s). Euthymic participants with a history of MDD-s recruited in summer-fall were followed-up in winter. At both visits, a structured clinical interview (DSM-5 criteria) and the Beck Depression Inventory II (BDI-II) were administered. Unesterified and total oxylipin pools were assayed by liquid chromatography tandem mass-spectrometry (LC-MS/MS). Precursor fatty acids were measured by gas chromatography. In nine unmedicated participants euthymic at baseline who met depression criteria in winter, BDI-II scores increased from 4.9±4.4 to 19.9±7.7. Four sEH-derived oxylipins increased in winter compared to summer-fall with moderate to large effect sizes. An auto-oxidation product (unesterified epoxyketooctadecadienoic acid) and lipoxygenase-derived 13-hydroxyoctadecadienoic acid also increased in winter. The cytochrome p450-derived 20-COOH-leukotriene B4 (unesterified) and total 14(15)-epoxyeicosatetraenoic acid, and the sEH-derived 14,15-dihydroxyeicostrienoic acid (unesterified), decreased in winter. We conclude that winter depression was associated with changes in cytochrome p450- and sEH-derived oxylipins, suggesting that seasonal shifts in omega-6 and omega-3 fatty acid metabolism mediated by sEH may underlie inflammatory states in symptomatic MDD-s.
Copyright © 2017 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cytochrome p450; Depression; Fatty acids; Lipidomics; Omega-3; Omega-6; Oxylipins; Seasonal major depression; Soluble epoxide hydrolase

Mesh:

Substances:

Year:  2017        PMID: 28259037      PMCID: PMC5611448          DOI: 10.1016/j.psychres.2017.02.056

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  53 in total

1.  Dietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathway.

Authors:  Robert Fischer; Anne Konkel; Heidrun Mehling; Katrin Blossey; Andrej Gapelyuk; Niels Wessel; Clemens von Schacky; Ralf Dechend; Dominik N Muller; Michael Rothe; Friedrich C Luft; Karsten Weylandt; Wolf-Hagen Schunck
Journal:  J Lipid Res       Date:  2014-03-16       Impact factor: 5.922

Review 2.  Biochemical studies on mammalian lipoxygenases.

Authors:  S Yamamoto; N Ueda; H Ehara; T Maruyama; C Yokoyama; S Kaneko; T Yoshimoto; N Komatsu; K Watanabe; A Hattori
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

3.  Arachidonic acid-metabolizing cytochrome P450 enzymes are targets of {omega}-3 fatty acids.

Authors:  Cosima Arnold; Marija Markovic; Katrin Blossey; Gerd Wallukat; Robert Fischer; Ralf Dechend; Anne Konkel; Clemens von Schacky; Friedrich C Luft; Dominik N Muller; Michael Rothe; Wolf-Hagen Schunck
Journal:  J Biol Chem       Date:  2010-08-23       Impact factor: 5.157

4.  Oxidative metabolism of linoleic acid by human leukocytes.

Authors:  O Reinaud; M Delaforge; J L Boucher; F Rocchiccioli; D Mansuy
Journal:  Biochem Biophys Res Commun       Date:  1989-06-15       Impact factor: 3.575

5.  EETs alleviate ox-LDL-induced inflammation by inhibiting LOX-1 receptor expression in rat pulmonary arterial endothelial cells.

Authors:  Jun-xia Jiang; Shui-juan Zhang; Ya-nan Liu; Xi-xi Lin; Yan-hong Sun; Hui-juan Shen; Xiao-feng Yan; Qiang-min Xie
Journal:  Eur J Pharmacol       Date:  2014-01-31       Impact factor: 4.432

6.  Seasonal affective disorder. A description of the syndrome and preliminary findings with light therapy.

Authors:  N E Rosenthal; D A Sack; J C Gillin; A J Lewy; F K Goodwin; Y Davenport; P S Mueller; D A Newsome; T A Wehr
Journal:  Arch Gen Psychiatry       Date:  1984-01

Review 7.  Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases.

Authors:  John D Imig; Bruce D Hammock
Journal:  Nat Rev Drug Discov       Date:  2009-10       Impact factor: 84.694

Review 8.  Seasonal affective disorder: a clinical update.

Authors:  Asa Westrin; Raymond W Lam
Journal:  Ann Clin Psychiatry       Date:  2007 Oct-Dec       Impact factor: 1.567

Review 9.  A meta-analysis of lipid peroxidation markers in major depression.

Authors:  Graham Mazereeuw; Nathan Herrmann; Ana C Andreazza; Maisha M Khan; Krista L Lanctôt
Journal:  Neuropsychiatr Dis Treat       Date:  2015-09-29       Impact factor: 2.570

Review 10.  Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs.

Authors:  Daniël Lakens
Journal:  Front Psychol       Date:  2013-11-26
View more
  16 in total

Review 1.  Metabolic/inflammatory/vascular comorbidity in psychiatric disorders; soluble epoxide hydrolase (sEH) as a possible new target.

Authors:  W Swardfager; M Hennebelle; D Yu; B D Hammock; A J Levitt; K Hashimoto; A Y Taha
Journal:  Neurosci Biobehav Rev       Date:  2018-02-02       Impact factor: 8.989

Review 2.  Humble beginnings with big goals: Small molecule soluble epoxide hydrolase inhibitors for treating CNS disorders.

Authors:  Sydney Zarriello; Julian P Tuazon; Sydney Corey; Samantha Schimmel; Mira Rajani; Anna Gorsky; Diego Incontri; Bruce D Hammock; Cesar V Borlongan
Journal:  Prog Neurobiol       Date:  2018-11-14       Impact factor: 11.685

3.  Soluble Epoxide Hydrolase-Derived Linoleic Acid Oxylipins in Serum Are Associated with Periventricular White Matter Hyperintensities and Vascular Cognitive Impairment.

Authors:  Di Yu; Marie Hennebelle; Demetrios J Sahlas; Joel Ramirez; Fuqiang Gao; Mario Masellis; Hugo Cogo-Moreira; Richard H Swartz; Nathan Herrmann; Pak Cheung Chan; Jacqueline A Pettersen; Donald T Stuss; Sandra E Black; Ameer Y Taha; Walter Swardfager
Journal:  Transl Stroke Res       Date:  2018-11-15       Impact factor: 6.829

4.  A single meal has the potential to alter brain oxylipin content.

Authors:  J E Norman; H H Aung; Y Otoki; Z Zhang; A Y Taha; J C Rutledge
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2020-01-30       Impact factor: 4.006

5.  Plasma Phosphatidylethanolamine and Triacylglycerol Fatty Acid Concentrations are Altered in Major Depressive Disorder Patients with Seasonal Pattern.

Authors:  Yurika Otoki; Marie Hennebelle; Anthony J Levitt; Kiyotaka Nakagawa; Walter Swardfager; Ameer Y Taha
Journal:  Lipids       Date:  2017-04-24       Impact factor: 1.880

Review 6.  Metabolomics Biomarkers for Precision Psychiatry.

Authors:  Pei-An Betty Shih
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

Review 7.  Epoxy Fatty Acids Are Promising Targets for Treatment of Pain, Cardiovascular Disease and Other Indications Characterized by Mitochondrial Dysfunction, Endoplasmic Stress and Inflammation.

Authors:  Cindy McReynolds; Christophe Morisseau; Karen Wagner; Bruce Hammock
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

8.  Deciphering the Differential Effective and Toxic Responses of Bupleuri Radix following the Induction of Chronic Unpredictable Mild Stress and in Healthy Rats Based on Serum Metabolic Profiles.

Authors:  Xiaoxia Gao; Meili Liang; Yuan Fang; Fang Zhao; Junsheng Tian; Xiang Zhang; Xuemei Qin
Journal:  Front Pharmacol       Date:  2018-01-15       Impact factor: 5.810

9.  Hypothesis: Clues From Mammalian Hibernation for Treating Patients With Anorexia Nervosa.

Authors:  Barbara Scolnick
Journal:  Front Psychol       Date:  2018-11-12

10.  Lipidomics in Major Depressive Disorder.

Authors:  Andreas Walther; Carlo Vittorio Cannistraci; Kai Simons; Claudio Durán; Mathias J Gerl; Susanne Wehrli; Clemens Kirschbaum
Journal:  Front Psychiatry       Date:  2018-10-15       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.